Odi Israel

Odi Israel has a diverse work experience in the biotechnology and pharmaceutical industry. They began their career as a Research Assistant at the University of Waterloo, where they managed a research project on the binding properties of Calmodulin mutant proteins. They then worked as a Research Assistant in Molecular Biology at the University of Toronto, where they drafted a research proposal that secured funding for investigating the development of Type 2 Diabetes.

Moving into the industry, Odi joined Therapure Biopharma Inc as a Project Coordinator in Drug Development. They collaborated with project managers on prioritizing project activities and monitored project timelines to prevent delays. They also served as a Research Associate, leading a team in the execution of a DSP process and managing the transfer of a venture project into the facility.

Odi then joined Patheon as a Project Manager, where they managed multiple active projects and implemented project reporting procedures. They later joined Thermo Fisher Scientific as a Business Manager for Commercial Manufacture, responsible for managing the business relationship with pharmaceutical clients and generating revenue through commercial manufacturing and delivery.

At CCRM, Odi worked as a Project Management Consultant, developing and implementing a project management framework for the GMP manufacturing business unit. They launched a project management playbook and various tools to support project lifecycle stages.

Currently, Odi is the Co-Founder and Chief Operating Officer of Specific Biologics, a gene-editing start-up. Odi drafted business plans, raised capital, and established operational functions such as HR, accounting, project management, and supply chain. They also developed operations strategies for short-term and long-term goals.

Overall, Odi has demonstrated expertise in project management, business development, and scientific research, with a focus on biologics and pharmaceuticals.

Odi Israel has a strong educational background, with degrees in both business and the sciences. In 2016 to 2019, Odi attended the Lazaridis School of Business & Economics at Wilfrid Laurier University, where they obtained a Master of Business Administration (MBA) degree. Prior to that, from 2013 to 2014, Odi pursued a Project Management Certification at the University of Waterloo. Additionally, Odi completed a MSc in Chemistry/Biochemistry from the University of Waterloo from 2007 to 2010, and a BSc in Biochemistry & Biotechnology from 2003 to 2007, also at the University of Waterloo.